Common use of IMPORTANT NOTE Clause in Contracts

IMPORTANT NOTE. Please answer every question. If the Issuer has completed portions of the Questionnaire on your behalf, please confirm the accuracy of that information. If your answer to a question is “Yes,” please provide details in the explanation. Unless otherwise stated, your answers should be given as of the date you sign the Questionnaire. Please note that certain questions are necessarily broad in scope, so if you have doubts regarding whether something should be included in your response please err on the side of over-inclusion. The Issuer may have additional follow-up questions for you in connection with the Offering. Once you have completed the Questionnaire, please sign it to indicate: (a) your consent for the Issuer to rely upon the information provided in this Questionnaire; (b) your acknowledgement that the Securities and Exchange Commission (the “SEC”) may require the Issuer to publicly disclose the information provided in this Questionnaire, and your consent to such public disclosure; (c) your agreement to promptly notify the Issuer of any changes in information provided in the Questionnaire occurring after the date you sign the Questionnaire; and (d) your confirmation that the information contained in the Questionnaire is true and correct, to the best of your knowledge and belief after a reasonable investigation, as of the date you sign the Questionnaire. THE EXISTENCE AND CONTENTS OF THE QUESTIONNAIRE, AS WELL AS YOUR ANSWERS AND ALL NOTES AND DRAFTS PREPARED BY YOU, ARE CONSIDERED EXTREMELY CONFIDENTIAL AND PROPRIETARY BY THE ISSUER AND SHOULD BE TREATED ACCORDINGLY. I hereby provide you with the following representations and information:

IMPORTANT NOTE. Please answer every question. If the Issuer Company has completed portions of the Questionnaire on your behalf, please confirm the accuracy of that information. If your answer to a question is “Yes,” please provide details a detailed explanation in the explanationcorresponding space provided. Unless otherwise stated, your answers should be given as of the date you sign the Questionnaire. Please note that certain Certain questions are necessarily broad in scope, so if . If you have doubts regarding whether something should be included in your response please err on the side of over-inclusion. The Issuer Company may have additional follow-up questions for you following your submission of this Questionnaire in connection with the Offering. Once you have completed the Questionnaire, please sign it to indicate: (ai) your consent for the Issuer Company to rely upon the information provided in this Questionnaire; (bii) your acknowledgement that the Securities and Exchange Commission (the “SEC”) may require the Issuer Company to publicly disclose the information provided in this Questionnaire, and your consent to such public disclosure; (ciii) your agreement to promptly notify the Issuer Company of any changes in information provided in the Questionnaire occurring after the date you sign the Questionnaire; and (div) your confirmation that the information contained in the Questionnaire is true and correct, to the best of your knowledge and belief after a reasonable investigation, as of the date you sign the Questionnaire. THE EXISTENCE AND CONTENTS OF THE QUESTIONNAIRE, AS WELL AS YOUR ANSWERS AND ALL NOTES AND DRAFTS PREPARED BY YOU, ARE CONSIDERED EXTREMELY CONFIDENTIAL AND PROPRIETARY BY THE ISSUER COMPANY AND SHOULD BE TREATED ACCORDINGLY. I hereby provide you with the following representations and information:THE COMPANY MAY DISCLOSE THE CONTENTS OF THIS QUESTIONNAIRE TO THE EXTENT REQUIRED BY APPLICABLE LAW, AS REASONABLY REQUIRED TO ESTABLISH AN EXEMPTION FROM STATE OR FEDERAL REGITRATION REQUIREMENTS FOR THE OFFERING OR AS REQUIRED BY THE SEC.

IMPORTANT NOTE. Please answer every question. If the Issuer Company has completed portions of the Questionnaire on your behalf, please confirm the accuracy of that information. If your answer to a question is “Yes,” please provide details a detailed explanation in the explanationcorresponding space provided. Unless otherwise stated, your answers should be given as of the date you sign the Questionnaire. Please note that certain Certain questions are necessarily broad in scope, so if . If you have doubts regarding whether something should be included in your response please err on the side of over-inclusion. The Issuer Company may have additional follow-up questions for you following your submission of this Questionnaire in connection with the Offering. Once you have completed the Questionnaire, please sign it to indicate: (ai) your consent for the Issuer Company to rely upon the information provided in this Questionnaire; (bii) your acknowledgement that the Securities and Exchange Commission (the “SEC”) may require the Issuer Company to publicly disclose the information provided in this Questionnaire, and your consent to such public disclosure; (ciii) your agreement to promptly notify the Issuer Company of any changes in information provided in the Questionnaire occurring after the date you sign the Questionnaire; and (div) your confirmation that the information contained in the Questionnaire is true and correct, to the best of your knowledge and belief after a reasonable investigation, as of the date you sign the Questionnaire. THE EXISTENCE AND CONTENTS OF THE QUESTIONNAIRE, AS WELL AS YOUR ANSWERS AND ALL NOTES AND DRAFTS PREPARED BY YOU, ARE CONSIDERED EXTREMELY CONFIDENTIAL AND PROPRIETARY BY THE ISSUER COMPANY AND SHOULD BE TREATED ACCORDINGLY. I hereby provide you with the following representations THE COMPANY MAY DISCLOSE THE CONTENTS OF THIS QUESTIONNAIRE TO THE EXTENT REQUIRED BY APPLICABLE LAW, AS REASONABLY REQUIRED TO ESTABLISH AN EXEMPTION FROM STATE OR FEDERAL REGITRATION REQUIREMENTS FOR THE OFFERING OR AS REQUIRED BY THE SEC. Name, Address, Telephone Number and informationEmail Your full name:

IMPORTANT NOTE. Please answer every question. If the Issuer has completed portions of the Questionnaire on your behalf, please confirm the accuracy of that information. If your answer to a question is “Yes,” please provide details in the explanation. Unless otherwise stated, your answers should be given as of the date you sign the Questionnaire. Please note that certain questions are necessarily broad in scope, so if you have doubts regarding whether something should be included in your response please err on the side of over-inclusion. The Issuer may have additional follow-up questions for you in connection with the Offering. Once you have completed the Questionnaire, please sign it to indicate: (ai) your consent for the Issuer to rely upon the information provided in this Questionnaire; (bii) your acknowledgement that the Securities and Exchange Commission (the “SEC”) may require the Issuer to publicly disclose the information provided in this Questionnaire, and your consent to such public disclosure; (ciii) your agreement to promptly notify the Issuer of any changes in information provided in the Questionnaire occurring after the date you sign the Questionnaire; and (div) your confirmation that the information contained in the Questionnaire is true and correct, to the best of your knowledge and belief after a reasonable investigation, as of the date you sign the Questionnaire. THE EXISTENCE AND CONTENTS OF THE QUESTIONNAIRE, AS WELL AS YOUR ANSWERS AND ALL NOTES AND DRAFTS PREPARED BY YOU, ARE CONSIDERED EXTREMELY CONFIDENTIAL AND PROPRIETARY BY THE ISSUER AND SHOULD BE TREATED ACCORDINGLY. I hereby Name, Address, Telephone Number and Email Your full name: Please provide you with the following representations and informationall previous, assumed or fictitious names or aliases:

IMPORTANT NOTE. Please answer every question. If the Issuer has completed portions of the Questionnaire on your behalf, please confirm the accuracy of that information. If your answer to a question is “Yes,” please provide details in the explanation. Please briefly describe the facts concerning any “Yes” answer below, including the date of the event in question. If you have copies of any relevant filings, orders or other documents attach them. Unless otherwise stated, your answers should be given as of the date you sign the Questionnaire. Please note that certain questions are necessarily broad in scope, so if you have doubts regarding whether something should be included in your response please err on the side of over-inclusion. The Issuer may have additional follow-up questions for you in connection with the Offering. Once you have completed the Questionnaire, please sign it to indicate: (ai) your consent for the Issuer to rely upon the information provided in this Questionnaire; (bii) your acknowledgement that the Securities and Exchange Commission (the “SEC”) may require in order for the Issuer to publicly be able to rely on the Rule 506 private placement exemption, the Issuer may disclose to investors the information provided in this Questionnairequestionnaire, and your consent to such public disclosure; (ciii) your agreement to promptly notify the Issuer of any changes in information provided in the Questionnaire occurring after the date you sign the Questionnaire; and (div) your confirmation that the information contained in the Questionnaire is true and correct, to the best of your knowledge and belief after a reasonable investigation, as of the date you sign the Questionnaire. THE EXISTENCE AND CONTENTS OF THE QUESTIONNAIRE, AS WELL AS YOUR ANSWERS AND ALL NOTES AND DRAFTS PREPARED BY YOU, ARE CONSIDERED EXTREMELY CONFIDENTIAL AND PROPRIETARY BY THE ISSUER AND SHOULD WILL BE TREATED ACCORDINGLY. I hereby provide you with This Questionnaire must be completed by the following representations and information:persons: The Issuer; Any predecessor of the Issuer; Any affiliated7 issuer; Any director, executive officer,8 other officer9 participating in the offering, general partner or managing member of the Issuer;

IMPORTANT NOTE. Please answer every question. If the Issuer has completed portions of the Questionnaire on your behalf, please confirm the accuracy of that information. If your answer to a question is “Yes,” please provide details in the explanation. Unless otherwise stated, your answers should be given as of the date you sign the Questionnaire. Please note that certain questions are necessarily broad in scope, so if you have doubts regarding whether something should be included in your response please err on the side of over-inclusion. The Issuer may have additional follow-up questions for you in connection with the Offering. Once you have completed the Questionnaire, please sign it to indicate: (ai) your consent for the Issuer to rely upon the information provided in this Questionnaire; (bii) your acknowledgement that the Securities and Exchange Commission (the “SEC”) may require the Issuer to publicly disclose the information provided in this Questionnaire, and your consent to such public disclosure; (ciii) your agreement to promptly notify the Issuer of any changes in information provided in the Questionnaire occurring after the date you sign the Questionnaire; and (div) your confirmation that the information contained in the Questionnaire is true and correct, to the best of your knowledge and belief after a reasonable investigation, as of the date you sign the Questionnaire. THE EXISTENCE AND CONTENTS OF THE QUESTIONNAIRE, AS WELL AS YOUR ANSWERS AND ALL NOTES AND DRAFTS PREPARED BY YOU, ARE CONSIDERED EXTREMELY CONFIDENTIAL AND PROPRIETARY BY THE ISSUER AND SHOULD BE TREATED ACCORDINGLY. I hereby provide you This Questionnaire must be completed by the following persons: · The Issuer. · Any predecessor of the Issuer. · Any “affiliated issuer.”[1] · Any director, executive officer,[2] other officer participating in the offering, general partner or managing member of the Issuer. · Any beneficial owner of 20% or more of the Issuer’s outstanding voting equity securities, calculated on the basis of voting power. · Any promoter[3] connected with the following representations and information:Issuer in any capacity at the time of the sale of securities. · Any person that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of securities (a “compensated solicitor”). · Any general partner or managing member of any compensated solicitor. · Any director, executive officer or other officer participating in the offering of any: o compensated solicitor; or o general partner or managing member of any compensated solicitor.